Vesting of Awards under HUTCHMED's Long Term Incentive Plan

HUTCHMED (China) Limited announced the vesting of non-performance based awards granted under its Long Term Incentive Plan (LTIP) on October 20, 2021. The awards were vested on October 20, 2025, for Dr Dan Eldar, Ms Edith Shih, and Professor Tony Mok, who are non-executive directors and an independent non-executive director, respectively. Each of them received 1,938 American depositary shares (ADS), with Ms Shih's shares being received by her employer, Hutchison International Limited. The announcement complies with the UK Market Abuse Regulation. HUTCHMED is a biopharmaceutical company focused on developing and commercializing targeted therapies and immunotherapies for cancer and immunological diseases.